Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Profiling technologies for the identification and characterization of small-molecule histone deacetylase inhibitors
Daiqing Liao
Drug Discovery Today Technologies (2015) Vol. 18, pp. 24-28
Open Access | Times Cited: 10

Showing 10 citing articles:

Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Terence C. S. Ho, Alex H. Y. Chan, A. Ganesan
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12460-12484
Open Access | Times Cited: 569
Next-generation of selective histone deacetylase inhibitors
Feifei Yang, Na Zhao, Di Ge, et al.
RSC Advances (2019) Vol. 9, Iss. 34, pp. 19571-19583
Open Access | Times Cited: 113
Plant Isoquinoline Alkaloid Berberine Exhibits Chromatin Remodeling by Modulation of Histone Deacetylase To Induce Growth Arrest and Apoptosis in the A549 Cell Line
Arunachalam Kalaiarasi, Chidambaram Anusha, Sankar Renu, et al.
Journal of Agricultural and Food Chemistry (2016) Vol. 64, Iss. 50, pp. 9542-9550
Closed Access | Times Cited: 65
Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?
Edibe Avcı, Pouya Sarvari, Rajkumar Savai, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 546-546
Open Access | Times Cited: 23
Technological advances and proteomic applications in drug discovery and target deconvolution: identification of the pleiotropic effects of statins
Cristina Banfi, Roberta Baetta, Erica Gianazza, et al.
Drug Discovery Today (2017) Vol. 22, Iss. 6, pp. 848-869
Closed Access | Times Cited: 25
Design and synthesis of imidazole based zinc binding groups as novel small molecule inhibitors targeting Histone deacetylase enzymes in lung cancer
Kandasamy Saravanan, Prabhu Subramani, Kannupal Srinivasan, et al.
Journal of Molecular Structure (2020) Vol. 1214, pp. 128177-128177
Closed Access | Times Cited: 20
Target Design of Novel Histone Deacetylase 6 Selective Inhibitors with 2-Mercaptoquinazolinone as the Cap Moiety
Hue Thi Buu Bui, Phuong Hong Nguyen, Phạm Minh Quân, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2204-2204
Open Access | Times Cited: 11
A Comparative Study of Target Engagement Assays for HDAC1 Inhibitor Profiling
Rosita R. Asawa, Alexey Zakharov, Taylor Niehoff, et al.
SLAS DISCOVERY (2019) Vol. 25, Iss. 3, pp. 253-264
Open Access | Times Cited: 12
Epigenomic alterations in cancer: mechanisms and therapeutic potential
Jaimie S. Gray, Sajad A. Wani, Moray J. Campbell
Clinical Science (2022) Vol. 136, Iss. 7, pp. 473-492
Closed Access | Times Cited: 7
Histone Deacetylase Inhibitors as Therapeutic Agents for Patients with Brain Tumors
Herbert H. Engelhard, Matthew Koshy, Sajani S. Lakka
Elsevier eBooks (2018), pp. 383-396
Closed Access | Times Cited: 1
Page 1

Scroll to top